University of Patras
Οξείες αιμορραγίες κατωτέρου πεπτικού: αιτίες, επίπτωση και φυσική ιστορία: η αξία των νεώτερων διαγνωστικών μεθόδων στην κλινική έκβαση των ασθενών
Abstract
dc:descriptionAcute lower gastrointestinal bleeding (ALGIB) is the bleeding from the gastrointestinal tract following the Treitz ligament from lesions of the small or large intestine, although it is mostly from the large intestine. Clinically, it appears as acute hematochezia, from bright red to marrow blood with clots and less often as a melena, depending on the location of the bleeding spot and its flow rate.It is a frequent emergency problem of everyday clinical practice. Patients with ALGIB exhibit many diagnostic and therapeutic dilemmas. There is a lack of data on the characteristics, management and clinical outcome of patients with ALGIB. Given the increase in its incidence in recent years due to aging population, co-morbidity and increased use of medication, there is a need to investigate the clinical features of these patients and to assess the value of new diagnostic methods in the clinical outcome of these patients.The present study progressively evaluated the characteristics and outcome of patients with ALGIB hospitalized in the University Hospital of Patras the last seven years, following an intensive diagnostic and therapeutic protocol.A high average age of the patients was observed in the present study and a high rate of co-morbidity. The mean age of the patients was 70.2 years, the majority of them had hematochezia (84.7%) and 87.9% had at least one disease. Thirty per cent of all patients were treated with antiplatelet drugs, while 18.2% were treated with anticoagulant agents, not only with acenocoumarol, but also with new direct non-vitamin K independent inhibitors of coagulation factors.In a high percentage (96.4%) of patients emergency endoscopy was performed during the first 24 hours after admission or immediately after resuscitation and adequate bowel cleansing. In patients with massive ongoing bleeding, urgent Computed Tomography Angiography (CTA) was performed at 8.7% from the radiological section. Twenty one point seven percent of these patients experienced active bleeding (extravasation) and were subjected to radiological embolism by the hospital's interventional radiology department. Gastroscopy was performed in 21% of patients, especially those who appeared with melena or dark brown blood. Enteroscopy of small intestine with wireless capsule was performed directly in patients with negative endoscopies of lower and upper digestive system. Subsequently, push enteroscopy was performed in patients with positive results in enteroscopy with capsule. Only one patient underwent intraoperative enteroscopy due to the surgeon's inability to locate the bleeding and due to the desire to perform limited enterectomy. Scintigraphy with labeled red cells was performed in 2 patients with suspicion of bleeding from Mechel’s diverticulum with a positive result. In colonoscopy, active bleeding was found in only 22.2% of the patients, the majority of whom received therapeutic intervention. The therapeutic interventions applied were haemostasis by injection of adrenaline 1:10.000 in 0.9% saline, hemostasis endoclips, Argon Plasma Coagulation (APC), combination of adrenaline injection and endoclips, combination of adrenaline injection and APC and polypectomy. Types of endoscopic hemostasis applied to a greater percentage were APC, double hemostasis of adrenaline injection combination and endoclips, and metal endoclips.Diverticular bleeding remained the most common cause of bleeding in this study (19.7%) but in a smaller percentage compared to previous studies. The second cause of bleeding is ischemic colitis and the third cause is the post-polypectomy bleeding. Their increased rates are associated with population aging, high rates of cardiovascular diseases, the use of antiplatelet/anticoagulant drugs and the use of serotonin 5HT receptor antagonists mainly by women of all ages. In addition, high rates of ALGIB from polyps and colon malignancies (5.3% and 8% in this study) are evidenced by anticoagulant treatment. These lesions, in the absence of anticoagulant therapy, cause chronic iron-deficiency anemia and no overt lower gastrointestinal bleeding. Between conventional and new anticoagulant treatment, patients taking NOAC’s (Novel Oral Anticoagulants) are more likely for their polyps and/or tumors to bleed than patients taking warfarin (18.6% vs. 8.8%). Vasal ectasias do not appear in a high proportion (5.1%) in the large intestine while it is the most common cause of small bowel bleeding (2.1% of all patients) and is associated with valvulopathy and renal failure.With the new diagnostic tools used in a timely and rational manner, diagnosis was set at a rate 94.9% of patients. In 88% of these bleeding sites were in the large intestine, while in 6.9% were in the small intestine. Endoscopic haemostasis was performed in 15.9%, radiographic embolism was performed at 1.9%, while only 1.1% of patients underwent urgent surgical haemostasis, as opposed to the highest rates reported in previous studies. Mortality in previous studies ranged between 2% and 10% while in our study mortality was low (2.5%) and was associated with active bleeding, site of bleeding in the small intestine and its in-hospital appearance, and concerned patients with severe coexisting conditions who had active bleeding while being hospitalized for another reason. Finally, the recurrence of bleeding occurred less (8.3%), while in patients undergoing anticoagulation the relapse of bleeding was higher in the warfarin group. In conclusion, the good outcome of the patients in our study reflects the need to define newer diagnostic methods as a protocol that promotes not only the diagnosis but also the treatment of patients with ALGIB.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Diamantopoulou, Georgia
- Διαμαντοπούλου, Γεωργία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45216